Endocannabinoids are arachidonic acid derivatives and part of a novel bioactive lipid signaling system, along with their G-coupled cannabinoid receptors (CB 1 and CB 2 ) and the enzymes involved in their biosynthesis and degradation. However, their roles in hematopoiesis and hematopoietic stem and progenitor cell (HSPC) functions are not well characterized. Here, we show that bone marrow stromal cells express endocannabinoids (anandamide and 2-arachidonylglycerol), whereas CB 2 receptors are expressed in human and murine HSPCs. On ligand stimulation with CB 2 agonists, CB 2 receptors induced chemotaxis, migration, and enhanced colony formation of bone marrow cells, which were mediated via ERK, PI3-kinase, and G␣i-Rac1 pathways. In vivo, the CB 2 agonist AM1241 induced mobilization of murine HSPCs with shortand long-term repopulating abilities. In addition, granulocyte colony-stimulating factor -induced mobilization of HSPCs was significantly decreased by specific CB 2 antagonists and was impaired in Cnr2 ؊/؊ cannabinoid type 2 receptor knockout mice. Taken together, these results demonstrate that the endocannabinoid system is involved in hematopoiesis and that CB 2 /CB 2 agonist axis mediates repopulation of hematopoiesis and mobilization of HSPCs. Thus, CB 2 agonists may be therapeutically applied in clinical conditions, such as bone marrow transplantation. (Blood. 2011;117(3):827-838)
IntroductionEndocannabinoids and exogenous cannabinoid ligands bind to and activate the cannabinoid receptors CB 1 and CB 2 . 1-3 Endocannabinoids are endogenous lipid mediators generated by many cell types both in the brain and peripheral tissues, which exert a broad range of biologic effects, such as cardiovascular, neurologic, and antiinflammatory effects. 4 Anandamide (AEA) and 2-arachidonoylglycerol (2-AG) are the 2 most widely studied endocannabinoids. The endocannabinoid system represents a pivotal neuroprotective mechanism both in acute forms of neuronal injury (such as stroke and traumatic brain injury) and chronic neurodegenerative disorders. [4][5][6][7][8] The synthetic and natural ligands of cannabinoid receptors exert various anti-inflammatory and neuroprotective effects by several mechanisms that include inhibiting the generation and release of proinflammatory cytokines, activation of cytoprotective signaling pathways, modulation of calcium homeostasis, and excitability via interactions with Ca ϩ2 , K ϩ , and Na ϩ channels as well as antioxidant properties of endocannabinoids. [4][5][6][7][8] Both the CB 1 and CB 2 receptors are 7-transmembrane G␣/i protein-coupled receptors (GPCRs) and are highly conserved during evolution. 2,9 The CB 2 receptor is predominantly expressed in the immune system, such as B and T cells, natural killer cells, monocytes, and neutrophils, where cannabinoids can modulate cytokine release and immune cell migration. Although the expression and function of cannabinoid receptors in mature hematologic and immune cells were reported, 9-14 the effect of cannabinoids on hematopoietic stem and pro...